| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-09 16:09:24 UTC |
|---|
| Update Date | 2021-09-14 15:45:14 UTC |
|---|
| HMDB ID | HMDB0060956 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | N-desmethylmirtazapine |
|---|
| Description | N-desmethylmirtazapine is a metabolite of mirtazapine. Mirtazapine (Remeron, Avanza, Zispin) is a noradrenergic and specific serotonergic antidepressant (NaSSA) which was introduced by Organon International in the United States in 1990 and is used primarily in the treatment of depression. It is also commonly used as an anxiolytic, hypnotic, antiemetic, and appetite stimulant. Structurally, mirtazapine can also be classified as a tetracyclic antidepressant (TeCA). (Wikipedia) |
|---|
| Structure | C1CN2C(CN1)C1=CC=CC=C1CC1=C2N=CC=C1 InChI=1S/C16H17N3/c1-2-6-14-12(4-1)10-13-5-3-7-18-16(13)19-9-8-17-11-15(14)19/h1-7,15,17H,8-11H2 |
|---|
| Synonyms | | Value | Source |
|---|
| Demethylmirtazapine | ChEBI | | Desmethyl mirtazapine | ChEBI | | Desmethylmirtazapine | ChEBI | | Normirtazapine | ChEBI | | ORG-3838 | ChEBI |
|
|---|
| Chemical Formula | C16H17N3 |
|---|
| Average Molecular Weight | 251.3263 |
|---|
| Monoisotopic Molecular Weight | 251.142247559 |
|---|
| IUPAC Name | 2,5,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(15),8,10,12,16,18-hexaene |
|---|
| Traditional Name | 2,5,19-triazatetracyclo[13.4.0.0²,⁷.0⁸,¹³]nonadeca-1(15),8,10,12,16,18-hexaene |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C1CN2C(CN1)C1=CC=CC=C1CC1=C2N=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C16H17N3/c1-2-6-14-12(4-1)10-13-5-3-7-18-16(13)19-9-8-17-11-15(14)19/h1-7,15,17H,8-11H2 |
|---|
| InChI Key | FGLAMNFOHWVQOH-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as piperazinoazepines. Piperazinoazepines are compounds containing a piperazinoazepine skeleton, which consists of an azepine ring fused to a piperazine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Piperazinoazepines |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Piperazinoazepines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzazepine
- Piperazino-azepine
- Dialkylarylamine
- Azepine
- Aralkylamine
- 1,4-diazinane
- Piperazine
- Imidolactam
- Benzenoid
- Pyridine
- Heteroaromatic compound
- Secondary aliphatic amine
- Azacycle
- Secondary amine
- Hydrocarbon derivative
- Amine
- Organopnictogen compound
- Organonitrogen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.03 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.3855 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.79 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 382.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 226.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 137.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 169.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 68.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 273.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 303.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 700.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 659.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 98.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 849.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 164.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 241.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 631.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 323.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 39.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-desmethylmirtazapine,1TMS,isomer #1 | C[Si](C)(C)N1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1 | 2470.1 | Semi standard non polar | 33892256 | | N-desmethylmirtazapine,1TMS,isomer #1 | C[Si](C)(C)N1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1 | 2515.6 | Standard non polar | 33892256 | | N-desmethylmirtazapine,1TMS,isomer #1 | C[Si](C)(C)N1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1 | 3164.9 | Standard polar | 33892256 | | N-desmethylmirtazapine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1 | 2685.2 | Semi standard non polar | 33892256 | | N-desmethylmirtazapine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1 | 2746.1 | Standard non polar | 33892256 | | N-desmethylmirtazapine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1 | 3346.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - N-desmethylmirtazapine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00di-0390000000-9f5ecf4547494620e4cb | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-desmethylmirtazapine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 10V, Positive-QTOF | splash10-0udi-0090000000-964bb70179075fb2b364 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 20V, Positive-QTOF | splash10-0udi-0090000000-640b11e80d6d5473fa22 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 40V, Positive-QTOF | splash10-0a4i-9850000000-24e8e860e77ddc872ac5 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 10V, Negative-QTOF | splash10-0udi-0090000000-fbf43ffa32573f90abc2 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 20V, Negative-QTOF | splash10-0udi-0090000000-c1d9598e4cb619a891df | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 40V, Negative-QTOF | splash10-0006-3920000000-5144479e97e40b108082 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 10V, Negative-QTOF | splash10-0udi-0090000000-32785a3fe19ac75a632b | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 20V, Negative-QTOF | splash10-0udi-0090000000-32785a3fe19ac75a632b | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 40V, Negative-QTOF | splash10-006x-1960000000-0e42ea918e27feb075b9 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 10V, Positive-QTOF | splash10-0udi-0090000000-a5f76b53c23417fe1729 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 20V, Positive-QTOF | splash10-0udi-0090000000-a5f76b53c23417fe1729 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-desmethylmirtazapine 40V, Positive-QTOF | splash10-0a4j-1490000000-bb9c59307aedfa1b68a3 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|